evenfolio
VanEckHealthPPH · Nasdaq

VanEck Pharmaceutical ETF (PPH)

Price
$109.44
11 Sept 2026
Assets
$1B
Total net assets
Expense ratio
0.36%
Category 1.00%
Yield
1.92%
Trailing distributions
3Y CAGR
12.3%-1.2%
Category 13.5%
5Y CAGR
10.3%+8.4%
Category 1.9%
Loading NAV history…
VanEck Pharmaceutical ETF

Calendar-year returns

Fund only: no comparison series covers this fund's history.

Risk statistics

Five years of daily closes. Risk-free rate 4% a year.

Standard deviation
Maximum drawdown
Sharpe ratio
Sortino ratio
Beta
Alpha
Information ratio
Upside capture
Downside capture
Tracking error
Trailing returns compared with benchmark
Period1M3M6MYTD1Y3YCAGR5YCAGR10YCAGRLaunchCAGR
ETF-1.8%+3.4%+6.3%+7.6%+24.1%+12.3%+10.3%+8.6%+6.2%
Health average-1.4%12.4%20.6%14.7%31.2%13.5%1.9%9.5%10.7%
Difference-0.4%-9.0%-14.2%-7.1%-7.2%-1.2%+8.4%-0.9%-4.5%

Holdings

The 10 largest positions make up 72.8% of the fund.

Top holdings

Largest holdings by weight
TickerHoldingWeight
LLYEli Lilly and Co19.11%
MRKMerck & Co Inc10.96%
NVSNovartis AG ADR10.06%
PFEPfizer Inc5.05%
BMYBristol-Myers Squibb Co4.98%
NVONovo Nordisk AS ADR4.92%
MCKMcKesson Corp4.70%
ABBVAbbVie Inc4.48%
JNJJohnson & Johnson4.43%
GSKGSK PLC ADR4.13%

Portfolio valuation

Weighted averages of what the fund holds.

P/E
24.7
P/B
4.4
P/S
1.6
P/CF
15.7

Sector allocation

Share of the equity the fund holds.

100.0%Health care1 sectors
  1. Health care100.0%

Asset mix

  • Stocks100.0%

ETF details

Issuer
VanEck
Category
Equity · Health
Ticker
PPH
Exchange
Nasdaq
Inception
20 Dec 2011 (14.7 years)
Structure
Exchange Traded Fund
Expense ratio
0.36% (category 1.00%)
Holdings turnover
30% (category 51%)
Distribution yield
1.92%
Beta, 3 years
0.43
Total net assets
$1B

Prices and returns as of 11 Sept 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.

Other health ETFs

Other ETFs in the Health category.

Search

Search funds, pages and tools